OxCan ^Companies

OxCan is a startup organization that specializes in early lung cancer detection using machine learning and liquid biopsy. Their multidisciplinary team, consisting of experts in cancer research, clinical medicine, machine learning, and business, is dedicated to bringing hope to cancer patients and their families worldwide. OxCan is pioneering the development of blood-based liquid biopsy tests for early cancer detection and has recently completed a seed financing round with support from various investors. They are collaborating with Oxford University Hospitals and the Oxford Radcliffe Biobank to identify cancer biomarkers and improve the accuracy of their detection methods.